You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 29, 2024

Investigational Drug Information for Tideglusib


✉ Email this page to a colleague

« Back to Dashboard


What is the development status for investigational drug Tideglusib?

Tideglusib is an investigational drug.

There have been 8 clinical trials for Tideglusib. The most recent clinical trial was a Phase 2 trial, which was initiated on August 23rd 2021.

The most common disease conditions in clinical trials are Myotonic Dystrophy, Alzheimer Disease, and Paralysis. The leading clinical trial sponsors are AMO Pharma Limited, Noscira SA, and Evdokia Anagnostou.

There are seventeen US patents protecting this investigational drug and one hundred and ten international patents.

Recent Clinical Trials for Tideglusib
TitleSponsorPhase
Tideglusib for the Treatment of Amyotrophic Lateral SclerosisCantonal Hospital of St. GallenPhase 2
Tideglusib for the Treatment of Amyotrophic Lateral SclerosisUniversity of BernPhase 2
Tideglusib for the Treatment of Amyotrophic Lateral SclerosisUniversity of Lausanne HospitalsPhase 2

See all Tideglusib clinical trials

Clinical Trial Summary for Tideglusib

Top disease conditions for Tideglusib
Top clinical trial sponsors for Tideglusib

See all Tideglusib clinical trials

US Patents for Tideglusib

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Tideglusib ⤷  Try a Trial Compositions and methods for treating cancers CEDARS-SINAI MEDICAL CENTER (Los Angeles, CA) ⤷  Try a Trial
Tideglusib ⤷  Try a Trial Reprogramming fibroblasts into cardiomyocytes THE J. DAVID GLADSTONE INSTITUTES, A TESTAMENTARY TRUST ESTABLISHED UNDER THE WILL OF J. DAVID GLADSTONE (San Francisco, CA) ⤷  Try a Trial
Tideglusib ⤷  Try a Trial Thermoreversible compositions for administration of therapeutic agents Frequency Therapeutics, Inc. (Woburn, MA) ⤷  Try a Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.